www.expressindia.com - Weather | Horoscope | Stocks | RSS
expressindia web city
HomeBlogsCricketAstrology TendersClassifieds Reader Comments Hotels
Sign In / Register | Archive
Expressindia » Story

Optra, TCS to create bio-medical imaging software solution

Font Size

Express news service

Posted: Feb 03, 2008 at 0116 hrs IST

Pune, February 2 The IT industry in the city is finally moving beyond the "Cyber Coolie" image. And with a vengeance.

Optra systems, a city-based Lifescience and healthcare imaging informatics company, has announced its partnership with Tata Consultancy Services (TCS), to jointly design and implement complete imaging software solution for the Life science and health care industry. Clients would include Pharma, Biotech and instrumentation companies as well as hospitals.

"Information generated by cutting edge biotech research is in both in the data format as well as the image format. While TCS would look after the data aspect, we will look at the imaging aspect," said Abhijeet Gholap, CEO and president, Optra, explaining the synergy behind the tie-up.

Gholap, who has an M.Tech with specialisation in bio-medical imaging from IIT Mumbai and has worked with Siemens Medical systems in the US, explained that a top-of -the-line pharmaceutical company spends an average of two billion dollars and seven years in order to launch a new drug in the market. "That's where we come in. We can help lower costs considerably," he said. Dr M Vidyasagar, executive vice-president for advanced technology, TCS said he was very excited about the partnership.

He said TCS has a very successful R&D program in the life sciences, and the partnership would help complement and extend TCS' internal capabilities in developing integrated in-silico platforms for drug discovery and development. With this partnership, the TCS' Co-Innovation Network (COIN), an ecosystem that promotes technology innovation, will expand its portfolio to include the healthcare industry.

According to figures provided by OPTRA, the US market for medical imaging was valued at a little more than $4.9 billion in 2006 and is expected to grow at an rate of 11.9 per cent to reach over $8.4 billion in 2011. For now, OPTRA and TCS are concentrating on markets in Europe and the US. "We are in talks with Indian pharma companies like Dr Reddy's and Ranbaxy, but the Indian market is not just there yet," feels Gholap.

Discuss this story on expressindia forums
Post Comments
Name* Email ID*
Subject* Country*
Message*
Characters remaining
 
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
I agree to the terms of use.

Latest News

Business

Showbiz

Sports

Rushdie cancels India visit, says 'paid assassins' out to kill him

Narendra Modi takes Sadbhavna Mission to Godhra

Age row: SC dismisses appeal supportive of Army chief's view

Law Commission for making honour killings non-bailable offence

Oz MP tells immigrants to learn English to stop racism

Uma Bharti's comments on Rahul not important: Azad

Digvijay rubbishes reports of quitting as UP poll in-charge

More
© 2011 The Indian Express Limited. All rights reserved
Advertise With Us | Privacy Policy | Feedback | Express Group | Site Map